- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
Event 33 results
Webinar
May 21, 2020
Congressional Investigations: A Bipartisan Conversation With Chief Counsels During the COVID-19 Pandemic
Webinar
April 22, 2020
COVID-19 Issues for Manufacturers
Webinar
April 3, 2020
Latest Congressional and CMS Actions Related to COVID-19
Webinar
March 27, 2020
Impact of Congressional Actions Related to COVID-19 on Healthcare Providers
Webinar
January 30, 2020
Congress 2020: The Year Ahead
Webinar
September 12, 2019
Open Borders for Rx Drugs? The Trump Administration’s Move to Authorize Prescription Drug Importation
Speaking Engagement
March 14, 2019
Tom Spulak to Speak at PREA Defined Contribution Plans Affinity Group Annual Spring Conference
Webinar
January 23, 2019
King & Spalding e-Learn: Washington Insight: How Will the New House Democratic Majority Affect Your Interests?
Webinar
November 28, 2018
Washington Insight: What Will Election 2018 Mean for Healthcare, Medical Device and Pharma Companies
Webinar
November 8, 2018
King & Spalding e-Learn: Washington Insight: What Will Election 2018 Mean for You?